We report the case of a 10-year-old boy having a recurrent craniopharyngioma with nasopharyngeal extension during a course of growth hormone therapy, in whom the nasopharyngeal craniopharyngioma was totally resected despite its extensive growth by using a transbasal approach. There has been no evidence of recurrence during 6 years of follow-up. A literature review was made with respect to nasopharyngeal extension of craniopharyngiomas, and the efficacy of the transbasal approach for those tumors is discussed.

Keywords:
Craniopharyngioma, Recurrent tumor, Nasopharyngeal extension, Growth hormone therapy, Transbasal approach
1.
Wisoff JH: Surgical management of recurrent craniopharyngiomas. Pediatr Neurosurg 1994;21(suppl 1):108–113.
2.
Benitez WI, Sartor KJ, Angtuaco EJC: Craniopharyngioma presenting as a nasopharyngeal mass: CT and MR findings. J Comput Assist Tomogr 1988;12:1068–1072.
3.
Bret P, Beziat JL: Crâniopharyngiome sphénoid-naso-pharyngé. Un cas avec exérèse radicale par maxillotomie de Le Fort I. Neurochirurgie 1993;39:235–240.
4.
Byrne MN, Sessions DG: Nasopharyngeal craniopharyngioma. Case report and literature review. Ann Otol Rhinol Laryngol 1990;99:633–639.
5.
Chakrabarty A, Mitchell P, Bridges LR: Craniopharyngioma invading the nasal and paranasal spaces, and presenting as nasal obstruction. Br J Neurosurg 1998;12:361–363.
6.
Gili AB, Garcia GB: Craneofaringioma de nasofaringe. A propósito de un caso. Acta Otorrinolaringol Esp 1991;42:269–272.
7.
Graziani N, Donnet A, Bugha TN, Dufour H, Figarella-Branger D, Grisoli F: Ectopic basisphenoidal craniopharyngioma: Case report and review of the literature. Neurosurgery 1994;34:346–349.
8.
Kanungo N, Just N, Black M, Mohr G, Glikstein R, Rochon L: Nasopharyngeal craniopharyngioma in an unusual location. AJNR 1995;16:1372–1374.
9.
Lewin R, Ruffolo E, Saraceno C: Craniopharyngioma arising in the pharyngeal hypophysis. South Med J 1984;77:1519–1523.
10.
Maiuri F, Corriero G, Elefante R, Cirillo S, Giamundo A: Craniopharyngioma of the cranial base and nasopharynx. Surg Neurol 1987;27:191–194.
11.
Mukada K, Mori S, Matsumura S, Uozumi T, Goishi J: Infrasellar craniopharyngioma. Surg Neurol 1984;21:565–571.
12.
Pheline C, Jamois Y, Engel P, Leguyarder B, Penot JC: Craniopharyngiome ectopique basi-sphénoidal. Abord par voie basse, naso-septale, puis antro-ethmoidale. Neurochirurgie 1981;27:221–224.
13.
De Vile CJ, Grant DB, Kendall BE, Neville BGR, Stanhope R, Watkins KE, Hayward RD: Management of childhood craniopharyngioma: Can the morbidity of radical surgery be predicted? J Neurosurg 1996;85:73–81.
14.
Fischer EG, Welch K, Shillito J Jr, Winston KR, Tarbell NJ: Craniopharyngioma in children. Long-term effects of conservative surgical procedures combined with radiation therapy. J Neurosurg 1990;73:534–540.
15.
Hoffman HJ, De Silva M, Humphreys RP, Drake JM, Smith ML, Blaser SI: Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 1992;76:47–52.
16.
Tomita T, McLone DG: Radical resections of childhood craniopharyngiomas. Pediatr Neurosurg 1993;19:6–14.
17.
Yaşargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P: Total removal of craniopharyngioma. Approaches and long-term results in 144 patients. J Neurosurg 1990;73:3–11.
18.
Derome PJ, Guiot G: Surgical approaches to the sphenoidal and clival areas; in Krayenbuhl H ed): Advances and Technical Standards in Neurosurgery. Wien, Springer-Verlag, 1979, vol 6, pp 101–136.
19.
Illum P, Elbrønd O, Nehen AM: Surgical treatment of nasopharyngeal craniopharyngioma. Radical removal by the transpalatal approach. J Laryngol Otol 1977;91:227–233.
20.
Maier HC: Craniopharyngioma with erosion and drainage into the nasopharynx. An autobiographic case report. J Neurosurg 1985;62:132–134.
21.
Majlessi H, Shariat AS, Katirai A: Nasopharyngeal craniopharyngioma. Case report. J Neurosurg 1978;49:119–120.
22.
Erdheim J: Über Hypophysengangsgeschwülste und Hirncholesteatome. Sitzungsber Akad Wissensch Math Naturwiss Cl Wien 1904;113:537–726.
23.
Hoffman HJ: Comment on Graziani N, Donnet A, Bugha TN, Dufour H, Figarella-Branger D, Grisoli F: Ectopic basisphenoidal craniopharyngioma: Case report and review of the literature. Neurosurgery 1994;34:346–349.
24.
Prasad U, Kwi NK: Clinical records. Nasopharyngeal craniopharyngioma. J Laryngol Otol 1975;89:445–452.
25.
Ishiyama R, Yasue M, Sanada S, Yuki K, Nakamura N: Rare cases of craniopharyngioma extending into the nasopharynx. Two case reports. Neurol Med Chir (Tokyo) 1977;17:71–77.
26.
Kawakami K, Yamanouchi Y, Kubota C, Kawamura Y, Matsumura H: An extensive transbasal approach to frontal skull-base tumors. Technical note. J Neurosurg 1991;74:1011–1013.
27.
Spetzler RF, Herman JM, Beals S, Joganic E, Milligan J: Preservation of olfaction in anterior craniofacial approaches. J Neurosurg 1993;79:48–52.
28.
Derome PJ: Surgical management of tumours invading the skull base. Can J Neurol Sci 1985;12:345–347.
29.
Clayton PE, Price DA, Shalet SM, Gattemaneni HR: Craniopharyngioma recurrence and growth hormone therapy. Lancet 1988;1:642.
30.
Price DA, Wilton P, Jonsson R, Albertsson-Wikland K, Chatelain P, Cutfield W, Ranke MB: Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: An analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm Res 1998;49:91–97.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.